GPR35 agonist (Sosei Heptares/GlaxoSmithKline)

N/A

Report date: 2025/03/20 15:34:05
NME

Base Information

Drug NameGPR35 agonist (Sosei Heptares/GlaxoSmithKline)
Drug Alias NameGPR35 agonist (Sosei Heptares/GSK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 35 agonists
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcNxera Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A